-+ 0.00%
-+ 0.00%
-+ 0.00%

PRESS RELEASE: RILZABRUTINIB GRANTED ORPHAN DRUG DESIGNATION IN THE US FOR SICKLE CELL DISEASE

Reuters·06/03/2025 05:00:00

Please log in to view news